C Difficile clinical trials

Explore recruiting c difficile clinical trials.

Recruiting c difficile studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

C Difficile trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides difficile Infection in Individuals 18 Years of Age and Above

Greece, Spain, France, Germany, Italy, Hungary +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of EXL01 a new Live Biotherapeutic Product to prevent recurrence of Clostridioides difficile infection in high-risk patients. LIVEDIFF

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

VANCALLO - Prevention of C. difficile infections by oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a randomized double-blind placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dose and Duration in critically ill patients

Netherlands, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I)

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

C Difficile trials by city

C Difficile in Toronto C Difficile in Vancouver C Difficile in Montreal C Difficile in Calgary C Difficile in Edmonton C Difficile in Ottawa C Difficile in Winnipeg C Difficile in Quebec City C Difficile in Hamilton C Difficile in Kitchener C Difficile in London C Difficile in Halifax C Difficile in New York C Difficile in Los Angeles C Difficile in Chicago C Difficile in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease